A Rare Opportunity? NIH Program For Rare Diseases May Have Big Payoff For Drug Development
This article was originally published in RPM Report
Executive Summary
NIH Director Francis Collins is very excited about a $24 million program to de-risk small molecule treatments for rare disorders. You should be too.